Actively Recruiting
Screening Brain MRI in Adults with Newly Diagnosed Stage IV Non-Oncogene Addicted Non-Small Cell Lung Cancer
Led by University Medical Center Groningen · Updated on 2026-06-09
100
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This research aims to evaluate the value of performing an MRI scan of the brain in patients who have newly diagnosed stage IV non-oncogene addicted non-small cell lung cancer NSCLC and are fit for systemic treatment without symptoms of brain disease. The study focuses on assessing the clinical benefit of this brain imaging procedure to detect brain involvement early in this patient group. Participants will undergo an MRI scan of the brain as a screening test to identify any brain disease. This screening is conducted in patients who do not show symptoms of brain disease and have no oncogene mutations that have approved targeted treatments. The MRI scan is the main intervention in this study, with no placebo or comparison group mentioned. During the study, participants will be evaluated up to six months after the MRI to measure its clinical value. Researchers will assess the usefulness of the MRI findings in patient care. Participants will undergo standard clinical evaluations by their oncologist, and the study will monitor outcomes related to brain disease detection and patient health over this period.
CONDITIONS
Brief Title
Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer
Research Team
F
F. Bensch, MD, PhD
L
L.B.M. Hijmering, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
